Concepedia

Publication | Open Access

Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen‐independent prostate carcinoma

35

Citations

31

References

2003

Year

Abstract

Cyclophosphamide, prednisone, and DES represent a well tolerated, low-cost combination therapy with significant activity in the treatment of patients with AIPC.

References

YearCitations

Page 1